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Tumor suppressor genes act as recessive determinants of cancer. These genes contribute to the normal
phenotype and arerequired forregulating cell growthanddifferentiationduringdevelopment. Inactivation
oftumor suppressor genes leads to an unrestricted pattern ofgrowth in specific cell types. In Drosophila,
a series of genes have been identified that cause tissue-specific tumors after mutation. Of these, the
lethal(2)giant larvae (1(2)gl) gene is the best studied. Homozygous 1(2)gl mutations cause the development
of malignant tumors in the brain and the imaginal discs. Genomic DNA from the 1(2)gl locus has been
cloned, introduced back into the genome of 1(2)gl-deficient animals, and shown to reinstate normal de-
velopment. The nucleotide sequence of the 1(2)gl gene has been determined, as well as the sequences of
twoclassesoftranscripts. Analysisofthespatialdistribution ofboth1(2)gltranscriptsandproteinsrevealed
that during early embryogenesis the 1(2)gl gene is uniformly expressed in all cells and tissues. In late
embryos, the 1(2)gl expression becomes gradually restricted to tissues presenting no morphological or
neoplastic alteration in the mutant animals. Further mosaic experiments revealed that 1(2)gl gene loss
can cause three distinct phenotypes: neoplastic transformation, abnormal differentiation, and normal
development. These phenotypes depend upon the extent of gene activity in the stem cells prior to the
formation of 1(2)gl- clones. These analyses indicate that the critical period for the establishment of
tumorigenesis occurs during early embryogenesis at a time when the 1(2)gl expression is most intense in
all cells.
Introduction
About 20 years ago, studies in the field ofDrosophila
and human genetics revealed that neoplasia may result
from recessive mutations in regulatory genes control-
lingcell growth and differentiation (1-3). InDrosophila
melanogaster, recessive mutations in a series of genes
were shown to interrupt the differentiation of certain
primordial cells and result in uncontrolled and invasive
cell proliferation (4-6). As a consequence, the mutant
animals formmalignanttumors ineithertheneuroblasts
ofthe optic centers, the imaginal disc cells, or the blood
cells. Simultaneous with the appearance and growth of
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the neoplasms, the development ofthe mutated animals
becomes impaired, and these animals die as larvae or
pseudopupae.
In Drosophila melanogaster, the best characterized
of these loci is the lethal (2) giant larvae (1(2)gl) gene.
Homozygous mutations of the 1(2)gl locus are respon-
sible for the malignant transformation of two distinct
tissues: the neuroblasts of the presumptive adult optic
centers in the larval brain and the imaginal disc cells
(1,7). In homozygous 1(2)gl-deficient animals, these ab-
normalities firstbecome visible in the third larvalinstar
priorto the metamorphosis ofthe larvae. The tumorous
growth produces a complex syndrome characterized by
bloatingofthe larvae, theunderdevelopment ofthering
gland, and atrophy ofthe fat bodies. However, the un-
derdevelopment ofothertissues such as the gonads and
the imaginal cells of the salivary glands occurs before
the outgrowth of the tumors and can thus be directly
attributed to the absence of1(2)gl gene activity in these
tissues (8).
Using techniques of molecular biology, we haveMERZ ET AL.
cloned the 1(2)gl gene (9) and subjected it to molecular
analysis (10). This approach has unequivocally demon-
strated thatthetumorous phenotyperesultsfrom alack
ofgene function. Furthermore, we were able to prevent
tumorigenesis by reintegrating a normal copy of this
gene into the genome of1(2)gl-deficient animals (10,11).
Such successful gene therapy indicates that the 1(2)gl
gene appears to have the characteristics of a tumor
suppressor or antioncogene similar to those recently
described in humans (12-15).
The molecular analysis of the 1(2)gl gene, located at
the cytological band 21A on the left arm ofchromosome
2 (9,16), has provided insights into both the biochemical
nature of the gene and its mode of action during the
development (9-11) but has not yet given any convinc-
ing clues to any particular function. Elucidation ofthis
function requires information on the expression of the
1(2)gl gene, in particular on the spatio-temporal pattern
of expression of the 1(2)gl transcripts and 1(2)gl pro-
teins, on the intracellular localization ofthe 1(2)gl pro-
teins and on the critical periods ofgene expression that
prevent the formation oftumors or any other patholog-
ical manifestations. The relevance of this information
shouldthen be assessed byintroducingspecificallymod-
ified 1(2)gl gene constructs that should allow us to de-
termine the spatial and temporal limits of gene action
as well as to define the functional domains ofthe 1(2)gl
gene and its products. In this article, we present our
recent progress inthe analysis of1(2)gl gene expression
and the preliminary results that we have obtained by
reverse genetics to assess whether the implications of
these analyses are relevant to tumorigenesis.
Results
Spatio-temporal Pattern of 1(2)gl
Expression
Northern blot analysis has revealed that the 1(2)gl
gene displays developmentally biphasic expression with
an intense period during early embryogenesis and a
second period during the larval-pupal transition phase
(9).
The availability of molecular probes for the 1(2)gl
transcripts and antibodies for the 1(2)gl proteins has
allowed us to investigate the spatial limits of 1(2)gl
expression during embryogenesis. As shown in Figure
1, the 1(2)gl transcripts are first detected at the end of
the syncytial blastoderm stage over all peripheral nu-
clei. At the cellularblastoderm stage, the 1(2)gl expres-
sion becomes stronger and is found over the cytoplasm
in all cells. This expression then remains uniform and
relatively intense over all embryonic cells during the
gastrulation and germ-band extension stages until
about 8.5 hr of embryonic development.
At the time of the dorsal closure (about 10 hr of de-
velopment), the expression of 1(2)gl gradually becomes
restricted to the epithelial cells of the midgut and the
salivary glands, where it persists until the end of em-
bryogenesis and disappears in all other tissues.
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FIGURE 1. Localization of 1(2)gl transcripts in wild-type embryos.
All sections are sagittal and oriented so that anterior is to the left
and dorsal up. Localization of1(2Jgltranscriptsin (a,b) 2.5-hr(c,d)
10.5-hr, and (e,f) 18- to20-hrembryos. (b,d, andf) Represent dark
field photomicrographs of the same sections as in (a,c, and e),
respectively. AMG, anterior midgut rudiment; Br, brain; HG,
hindgut; MG, midgut; Ph, pharynx; PMG, posterior midgut ru-
diment; VNS, ventral nervous system. From the formation ofthe
syncytialblastoderm untilgermbandretraction, the 1(2)gl expres-
sion is uniformly observed in all embryonic cells and then becomes
gradually restricted to the midgut and the salivary glands.
Immunostaining analysis has revealed that the
expression pattern of 1(2)gl proteins follows generally
the pattern of1(2)gl transcription (Fig. 2). Duringearly
embryogenesis, a general and uniform staining is ob-
served over all embryonic cells. In later embryonic
stages, the 1(2)gl proteins are detected in the midgut
and the salivary gland epithelia and, in addition, in the
axon projections forming the neuropile of the central
nervous system. The accumulation of 1(2)gl proteins in
the axons indicate that the 1(2)gl protein turnover and/
or translational efficiency ofthe 1(2)gl transcripts in the
neuroblasts may be different from that in other embry-
onic tissues.
Intracellular Localization of the l(2)gl
Proteins
At the cellular level, the 1(2)gl proteins appear to be
present both in the cytoplasm and bound to the plasma
membrane during the early embryonic stages, whereas
inlaterstagesthe1(2)gl proteinsappeartobeassociated
essentially with the cell periphery. In particular, the
1(2)gl proteins present in the polyhedral cells of the
midgut epithelium are restricted to domains of the
plasmamembranefacingcontiguous cellsand aretotally
absent from the basal and apical membranes ofthe ep-
ithelial cells.
Although no suggestion of a direct membrane asso-
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FIGURE 2. Expression of1(2)gl proteins in wild-type embryos. All
sections are sagittal and oriented so that anterior is to the left and
dorsal up. The sections were stained with rabbit anti-1(2)gl anti-
bodies. Localization of 1(2)gl proteins in (a) 2.5-hr, (b) 12-hr, and
(c) 18- to 20-hr embryos. The expression of the 1(2)gl proteins
coincides generally with the pattern of 1(2)gl transcription. The
accumulation of 1(2)gl proteins in the axon projections ofthe ven-
tral nervous systems (VNS) indicate that the 1(2)gl protein turn-
over and translational efficiency in the neuroblasts may be differ-
ent from that in the other embryonic tissues. In late embryos, the
1(2)gl proteins present in the polyhedral cells ofthe midgut (MG)
epithelium are associated with the plasma membranes facing con-
tiguous cells and are completely absent from the basal and apical
membranes of these cells.
ciation ofthe 1(2)gl proteins can be found inthe putative
1(2)gl amino acid sequence, such as anN-terminalleader
peptide orahighlyhydrophobictransmembrane domain
(10), we can showbyusingcell-fractionation procedures
that the p127 1(2)gl protein is tightly associated with
membranes (data not shown). However, the nature of
this binding is not yet known.
Critical Periods for Establishment of 1(2)gl
Neoplasia
Previous analysis has revealed that the 1(2)gl gene is
essentially activeduring embryogenesis and duringlate
third larval instar (9). These two phases of 1(2)gl gene
expression correspond to the two major periods of cell
proliferation during Drosophila development. It is
tempting to attribute this correlation to a direct repres-
sion ofcell proliferation oranindirect repression caused
by induced differentiation that limits the mitotic poten-
tial ofthe cells undergoing this process. However, this
hypothesis does nottake into consideration the fact that
the 1(2)gl-deficient embryos are able to complete their
embryogenesis normally. No apparent morphological or
histological differences can be detected in 1(2)gl-defi-
cient embryos, although the 1(2)gl embryonic cells have
already acquired tumorigenic potential, as shown by
transplantation of 1(2)gl embryonic cells into the ab-
domen ofadult hosts (7). The tumorigenic commitment
of embryonic cells suggests that the critical period for
establishment ofneoplasia takes place during early em-
bryonic development, when intense 1(2)gl gene activity
occurs.
A functional assay is required to determine the re-
spective contribution ofeachperiod of1(2)glexpression.
Such an analysis can be performed by means ofinducing
the development of 1(2)gl- clones in otherwise hetero-
zygous animals and by studying the fate of the clones
during development. For this purpose, we have taken
advantage ofthe availability ofafunctional 1(2)gl+ gene
associated with the X chromosome (11). Using crossing
over, we have introduced the gene into a ring X chro-
mosome that is preferentially lost duringthe first cleav-
age divisions of the early embryo but that can instead
be lost during subsequent mitoses, albeit less fre-
quently. With appropriate genetic markers, we have
been able to analyze the fate of 1(2)gl- clones and to
correlate the different l(2)gl phenotypes with the de-
velopmentphase whenthe 1(2)gl+ chromosomalloss has
taken place.
Analysis of the 1(2)gl mosaic animals indicates that
the neoplastic growth takes place in clones ofcells that
have lost the 1(2)gl gene in the preblastoderm syncytial
embryos prior to any expression ofthe 1(2)gl gene (Fig.
3). Clones that areproduced atembryonic stages du-ring
the first period of 1(2)gl expression do not display the
neoplastic phenotype but are unable to complete differ-
entiation. Finally, when the clones arise during the lar-
val stages, the 1(2)gl-deficient cells show.a nearly nor-
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FIGURE 3. Abnormalities produced by 1(2)gl- clones generated at
different periods of Drosophila development.
165MERZ ET AL.
mal or normal development. With the assumption that
the 1(2)gl activityis cellautonomous, these datasuggest
strongly that the critical period for the establishment
of 1(2)gl neoplasia is during early embryogenesis.
Dissection of the 1(2)gl Gene
Gene dissection should permit a more precise defi-
nition of the function of the 1(2)gl gene and a better
appreciation ofitsrole incausingmalignancies andother
developmental abnormalities. The cloning of the 1(2)gl
gene allows us to deliberately modify its structure and
to test the functional consequences of these structural
changes by using reverse genetics.
Previous gene transfer experiments have shown that
tumorigenesis canbepreventedbyintroducinganormal
copy of the 1(2)gl+ gene (Fig. 4), which encompasses a
13.1-kb DNA segment, into the germ line of 1(2)gl-de-
ficient animals (10,11). Furtherexperiments with trans-
posons containing resected 1(2)gl gene segments have
allowed us to delimit more precisely the essential do-
mains of the 1(2)gl gene.
Upstream Regulatory Elements in the
1(2)gl Gene
The nucleotide sequence analysis has
presence of two 2,8-kb repeats in the 5'
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FIGURE 4. Diagrams ofP-1(2)gl transposons. Above the 1(2)gl gen-
omic sequence is shownthe extent ofthe twotranscripts (including
the introns) that encode the p127 and p78 proteins, respectively.
The dashed lines represent the transcripts initiated in the first
repeat. The position of the initiation and termination codons are
indicated by N and C, respectively. On the right are the functional
capacities of the P-1(2)gl transposons to complement 1(2)gl defi-
ciencies with respect to tumor suppression. Restriction sites: B,
BamHl, E, EcoRl; K, Kpnl; Nh, Nhel; S, Sall; St, Stul; X,
Xbal.
gene (10). Theserepeats share 96%homology. Sequence
analysis ofa series ofcDNAs, Si mapping, and primer
extension experiments have shown that initiation of
transcription can occur in both repeats, at about 0.4 kb
downstream from their proximal limits. Depending on
the splicing pattern, this duplication leads to the syn-
thesis of transcripts that differ in the 5' region. These
variations are localized upstream of the coding region
and therefore have no effect on the 1(2)gl protein struc-
ture.
To determine whether each promoter can control the
overall 1(2)gl gene expression or directs a particular
pattern of expression, we have constructed P-element
transposons (Fig. 4) in which the 1(2)gl gene is under
the control of one or the other promoter region. The
results of P-mediated gene transfer experiments have
shown that each promoter region is fully able to govern
the expression of 1(2)gl gene.
Modified Gene Expression in P-1(2)gl-24
Transgenic Embryos
Truncation of the 3' region of the 1(2)gl gene has
allowed us to delineate more precisely the tumor sup-
d the pressor domain within the 1(2)gl protein. Deletion of a
f the 2.6-kb DNA segment removing the 1803 terminal nu-
)f the cleotides ofthe largest 1(2)gl transcripts and therefore
truncating 141 amino acids at the C-terminal extremity
of the p127 protein (P-1(2)gl-24 transposon), as shown
,Uffxxr in Figure 4, did notaffectthetumorsuppressorfunction
,p,o ofthe 1(2)gl gene (10). Immunoblot analysis ofthe pro-
teinssynthesizedbyP-1(2)gl-24embryoshasshownthat
+ the largest 1(2)gl protein is expressed in a shortened
form. The apparent molecular weight reduction corre-
+ sponds to atruncation ofthe 141 C-terminal amino acids
ofthe 1(2)gl and their replacement by a sequence of55
amino acids presumably provided by the read-through
+ into the flanking transposon sequence.
Recent immunostaining analysis of the distribution
and localization ofthe 1(2)gl proteins has revealed that
the 1(2)gl proteins are no longer associated with the
plasma membranes but are found diffused in the cyto-
plasm of early embryonic cells. These results suggest
that the membrane localization of the 1(2)gl proteins
+ does not necessarily play an important role in the reg-
ulation ofcell fate because the absence ofplasma mem-
+ brane association of the 1(2)gl proteins in P-1(2)gl-24
embryos does not lead to tumorigenesis. Furthermore,
these results suggest that the tumor suppressor func-
tion is only required transiently during early embry-
ogenesis.
Conclusions and Prospects
The isolation of the 1(2)gl gene leaves a number of
unresolved questions andparadoxes. Althoughthe gene
is expressed in awide variety oftissues, its inactivation
leads only to a small range oftumors. Other tissues are
also affected, but their growth properties are reduced
instead of enhanced. Thus, in the absence of 1(2)gl ac-
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tivity, three types of growth can occur in the same
organism: normal growth and differentiation ofthe lar-
val cells; atrophy of some adult cell lineages, such as
the germ line and the imaginal cells of the salivary
glands; and neoplastic transformation of the imaginal
disc cells and the neuroblasts ofthe presumptive adult
optic centers in the larval brain.
Equally perplexing is the delayed appearance of the
tumors. The malignant pattern ofgr-owth only becomes
visible during late larval life, althti it can be directly
correlated with the absence of gene expression during
early embryogenesis. Furthermore, the lack of 1(2)gl
expression has no direct visible effect on the 1(2)gl-
deficientembryos. Intheseembryosmorphogenesis and
histogenesis proceed normally. No overgrowth of any
tissue can be observed, indicating that the potential
tumorigenic cells first follow a normal pattern of de-
velopment with cessation of cell division during late
embryogenesis similar to that in wild-type embryos.
Anotherparadoxconsistsintheabsence ofmembrane
association ofthe modified p127 1(2)gl protein in the P-
1(2)gl-24 transgenic embryos. These embryos give rise
to perfectly viable animals. Thus, the importance ofthe
membrane association ofthe 1(2)glproteininthe control
ofnormaldevelopment is questionable. Furtherreverse
genetic experiments with specific modifications of the
1(2)gl gene will allow us to analyze the intracellular site
ofactionofthe 1(2)glproteinswithrespecttoprevention
oftumorigenesis.
How the 1(2)gl gene products achieve the control of
cell growth and cell differentiation remains unclear. It
is tempting to speculate that the 1(2)gl gene products
interact with othercomponents ofalongsignalingchain
of molecular events. These components may vary, de-
pending on the cellular context. Further genetic and
biochemical studies will reveal the nature ofthe genes
and the gene products interacting with 1(2)gl. These
studies will define the contribution ofthese genes in the
establishment oftumorigenesis.
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